Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts

  • 16 Accesses

  • 7 Citations


We had previously established a murine bone marrow-derived cell line, designated JBMΦ1.1, which displayed properties of normal macrophages, including the ability to perform macrophage-mediated cytolysis. It was also found that these cells could be induced by lipopolysaccharide (LPS) to produce reproducibly high levels of a cytolytic factor (CF) resembling tumor necrosis factor (TNF). This cell line was therefore selected for further studies on macrophage-mediated tumor cell lysis and CF production. Moreover, the CF production during incubation with LPS was higher in the absence of serum than in its presence, with a maximum at days 2–3 following the addition of LPS. A factor inhibitory to CF production (CIF) was detected in our laboratory in the supernatant of embryonic fibroblast cultures. We established the experimental conditions required for the optimal production and suppressive effect of CIF. High levels of CIF activity were obtained under conditions that promote fibroblast proliferation. Addition of embryonic fibroblast culture supernatant to the macrophages shortly before LPS suppressed both LPS-induced CF production and tumoricidal activity. CIF did not affect macrophage protein synthesis in the presence or absence of LPS. However, LPS-induced interleukin 1 release was partially (55%) suppressed by embryonic fibroblast culture supernatant. Our results show that CIF does not exert a general inactivating effect on the macrophages, although it may possibly affect other functions in addition to CF production and tumor cell lysis. The strong inhibition of both the latter properties further indicates that TNF-like CF is an important mediator in macrophage-mediated tumor cell lysis.

This is a preview of subscription content, log in to check access.


  1. 1.

    Adams DO (1980) Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J Immunol 124:286

  2. 2.

    Alexander P (1976) The function of the macrophage in malignant disease. Ann Rev Med 27:207

  3. 3.

    Cabilly S, Gallily R (1981) Artificial binding of macrophages to syngeneic cells elicits cytostasis but not cytolysis. Immunology 42:149

  4. 4.

    Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666

  5. 5.

    Currie GA (1978) Activated macrophages kill tumor cells by releasing arginase. Nature 273:758

  6. 6.

    Currie GA, Basham C (1975) Activated macrophages release a factor which lyses malignant cells but not normal cells. J Exp Med 142:1600

  7. 7.

    Farram E, Nelson DS (1980) Mechanism of action of mouse macrophages as antitumor effector cells: role of arginase. Cell Immunol 55:283

  8. 8.

    Farram E, Nelson M, Nelson DS, Moon DK (1982) Inhibition of cytokine production by a tumour cell product. Immunology 46:603

  9. 9.

    Fisch H, Gifford GE (1983) A photometric and plaque assay for macrophage-mediated tumor cell cytotoxicity. J Immunol Methods 57:311

  10. 10.

    Flick DA, Gifford GE (1984) Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J Immunol Methods 68:167

  11. 11.

    Flick DA, Gifford GE (1985) Tumor necrosis factor: In: Paul F Torrence (ed) Biological response modifiers. Academic Press, New York, p 171

  12. 12.

    Gery I, Davies P, Derr J, Krett N, Barranger JA (1981) Relationship between production and release of lymphocyte activating factor (interleukin 1) by murine macrophages. I. Effect of various agents. Cell Immunol 64:293

  13. 13.

    Gifford GE, Loewenstein J, Yamin A, Gallily R (1986) Correlation of macrophage-mediated tumor cell lysis with the production of macrophage cytolytic factor (CF). Preliminary characterization of a factor inhibiting CF production. Int J Cancer 37:73

  14. 14.

    Hayflick L (1965) Tissue cultures and mycoplasmas. Texas Rep Biol Med 23:285

  15. 15.

    Hibbs JB, Weinberg JB, Chapman HA (1980) Modulation of the tumoricidal function of activated macrophages by bacterial endotoxin and mammalian macrophage activation factor(s). Adv Exp Med Biol 121B:433

  16. 16.

    Johnson WJ, Somers SD, Adams DO (1984) Expression and development of macrophage activation for tumor cytotoxicity. Contemp Top Immunobiol 13:127

  17. 17.

    Klostergaard J, Reidarson TH, Granger GA (1984) Purification of murine macrophage cytotoxin (MTC). J Leuk Biol 35:229

  18. 18.

    Kull FC, Cuatrecasas P (1984) Necrosin: Purification and properties of a cytotoxin derived from a murine macrophagelike cell line. Proc Natl Acad Sci USA 81:7932

  19. 19.

    Loewenstein J, Gallily R (1984) Continuously proliferating cell lines with properties of normal differentiated macrophages established from long-term bone marrow cultures. 6th European Immunology Meeting, Interlaken, abstract, p 874

  20. 20.

    Loewenstein J, Gallily R (1985) Selective tumor cell lysis by non-specifically activated macrophages derived from long-term bone marrow cultures. In: Reichard S, Kojima M (eds) Macrophage Biology (Progress in Leukocyte Biology, Vol 4) Alan R Liss, New York, p 715

  21. 21.

    Loewenstein J, Rottem S, Gallily R (1983) Induction of macrophage-mediated cytolysis of neoplastic cells by mycoplasmas. Cell Immunol 77:290

  22. 22.

    Mannel DN, Moore RN, Mergenhagen SE (1980) Macrophages as a source of tumoricidal activity (tumor necrotizing factor). Infect Immun 30:532

  23. 23.

    Mannel DN, Falk W, Meltzer MS (1981) Inhibition of nonspecif tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor. Infect Immun 33:156

  24. 24.

    Meerpohl H-G, Lohmann-Matthes M-L, Fisher H (1976) Studies on the activation of mouse bone marrow-derived macrpophages by the macrophage cytotoxicity factor (MCF). Eur J Immunol 6:213

  25. 25.

    Meltzer MS (1981) Tumor cytotoxicity by lymphokine-activated macrophages: development of macrophage tumoricidal activity requires a sequence of reactions. Lymphokines 3:319

  26. 26.

    Nathan CF, Brukner LA, Silverstein SC, Cohen ZA (1979) Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide. J Exp Med 149:84

  27. 27.

    Nelson DS, Nelson M, Farram E, Inoue Y (1981) Cancer and subversion of host defenses. A review. Aust J Exp Biol Med Sci 59:229

  28. 28.

    Panet A (1983) Regulation of the antiviral and anticellular activities of interferon by exogenous double stranded RNA. Mol Cell Biochem 52:153

  29. 29.

    Reidarson TH, Levy III WE, Klostergaard J, Granger GA (1982) Inducible macrophage cytotoxins. I Biokinetics of activation and release in vitro. J Natl Cancer Inst 69:879

  30. 30.

    Reidarson Th, Granger GA, Klostergaard J (1982) Inducible macrophage cytotoxins. II. Tumor lysis mechanism involving target cell-binding proteases. J Natl Cancer Inst 69:889

Download references

Author information

Correspondence to Ruth Gallily.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gallily, R., Gifford, G.E. & Loewenstein, J. Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts. Cancer Immunol Immunother 23, 60–66 (1986). https://doi.org/10.1007/BF00205557

Download citation


  • Protein Synthesis
  • Tumor Necrosis Factor
  • Suppressive Effect
  • Factor Production
  • Strong Inhibition